Uveitis

S Muñoz-Fernández, E Martín-Mola - Best Practice & Research Clinical …, 2006 - Elsevier
Uveitis is a prevalent disease that mainly affects young people. It leads to a significant
number of visual losses. Acute anterior uveitis is the most prevalent form, and it is often …

Update in treatment of uveitic macular edema

S Koronis, P Stavrakas, M Balidis… - Drug design …, 2019 - Taylor & Francis
Macular edema (ME) represents the most common cause for visual loss among uveitis
patients. The management of uveitic macular edema (UME) may be challenging, due to its …

A grafted copolymer-based nanomicelles for topical ocular delivery of everolimus: Formulation, characterization, ex-vivo permeation, in-vitro ocular toxicity, and …

N Mehra, M Aqil, Y Sultana - European Journal of Pharmaceutical Sciences, 2021 - Elsevier
Abstract Treatment of posterior uveitis via topical route is desirable but cannot be achieved
by conventional drug delivery strategies. Therefore, the aim of this study is to develop a …

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

Y Wang, VM Wang, CC Chan - Eye, 2011 - nature.com
Although age-related macular degeneration (AMD) is not a classic inflammatory disease like
uveitis, inflammation has been found to have an important role in disease pathogenesis and …

Pharmacotherapy for uveitis: current management and emerging therapy

RJ Barry, QD Nguyen, RW Lee, PI Murray… - Clinical …, 2014 - Taylor & Francis
Uveitis, a group of conditions characterized by intraocular inflammation, is a major cause of
sight loss in the working population. Most uveitis seen in Western countries is noninfectious …

Current advances in the treatment of neovascular age-related macular degeneration

VM Villegas, LA Aranguren, JL Kovach… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Age-related macular degeneration (AMD) is the most common cause of
permanent central visual acuity loss in persons over 65 years of age in industrialized …

Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE …

QD Nguyen, MA Ibrahim, A Watters… - Journal of ophthalmic …, 2013 - Springer
Background The purpose of this study is to evaluate the ocular tolerability and efficacy of
sirolimus administered as subconjunctival or intravitreal injections in patients with non …

[HTML][HTML] Intravitreal sirolimus for noninfectious uveitis: a phase III sirolimus study assessing double-masked uveitis treatment (SAKURA)

QD Nguyen, PT Merrill, WL Clark, AS Banker… - Ophthalmology, 2016 - Elsevier
Purpose To evaluate the efficacy and safety of intravitreal sirolimus in the treatment of
noninfectious uveitis (NIU) of the posterior segment (ie, posterior, intermediate, or …

Emerging drugs for uveitis

T Larson, RB Nussenblatt, HN Sen - Expert opinion on emerging …, 2011 - Taylor & Francis
Introduction: Uveitis is a challenging disease covering both infectious and noninfectious
conditions. The current treatment strategies are hampered by the paucity of randomized …

Ultra‐thin, high strength, antibiotic‐eluting sutures for prevention of ophthalmic infection

KS Parikh, R Omiadze, A Josyula, R Shi… - Bioengineering & …, 2021 - Wiley Online Library
Sutures are applied almost universally at the site of trauma or surgery, making them an ideal
platform to modulate the local, postoperative biological response, and improve surgical …